Cochlear downgraded its full-year earnings forecast as cost-of-living pressures dented the revenue it earns from servicing implants, and fewer patients upgraded their hearing devices.
The company said on Friday it expected underlying net profit to be at the lower end of its $410 million to $430 million guidance range.
Loading...
Michael Smith is the health editor for The Australian Financial Review. He is based in Sydney. Connect with Michael on Twitter. Email Michael at michael.smith@afr.com